Patents matching “air”

US 11274305

Compositions and methods for in vivo excision of HIV-1 proviral DNA

United States Government as represented by the Department of Veterans Affairs · Granted Mar 15, 2022 · Expires Mar 10, 2042

US 11266676

MicroRNA in T cell activation

United States Government as represented by the Department of Veterans Affairs · Granted Mar 8, 2022 · Expires Mar 3, 2042

US 11266488

Tissue repair fiber membrane, preparation method and application thereof, and tissue repair product

Medprin Regenerative Medical Technologies Co., Ltd. · Granted Mar 8, 2022 · Expires Mar 3, 2042

US 11261152

Inhibitors of the N-terminal domain of the androgen receptor

United States Government as represented by the Department of Veterans Affairs · Granted Mar 1, 2022 · Expires Feb 24, 2042

US 11260050

Combination of cotinine plus antioxidant for treatment-resistant depression and correction of astrocytes functional deficit induced by depression and other neuropathological

United States Government as represented by the Department of Veterans Affairs · Granted Mar 1, 2022 · Expires Feb 24, 2042

US 11253445

Oxidative hair color remover in tablet or pellet form

Bright International, LLC · Granted Feb 22, 2022 · Expires Feb 17, 2042

US 11253489

Visual cycle modulators

The United States Government as Represented by The Department of Veteran Affairs · Granted Feb 22, 2022 · Expires Feb 17, 2042

US 11246961

Engineered scaffolds for vascularized tissue repair

The Regents of the University of California · Granted Feb 15, 2022 · Expires Feb 10, 2042

US 11246947

Recombinant AAV-crumbs homologue composition and methods for treating LCA-8 and progressive RP

Academisch Ziekenhuis Leiden h.o.d.n. Leids Universitair Medisch Centrum · Granted Feb 15, 2022 · Expires Feb 10, 2042

US 11242339

Chemical inhibition of the E3 ligase subunit FBXO7 confers neuroprotection and anti-inflammatory activity by stabilizing mitochondria

United States Government as represented by the Department of Veterans Affairs · Granted Feb 8, 2022 · Expires Feb 3, 2042

US 11236340

Method of reducing the effects of aging-associated impairment of neurogenesis comprising modulating c-c chemokine receptor type 3 (CCR3)

United States Government as represented by the Department of Veterans Affairs · Granted Feb 1, 2022 · Expires Jan 27, 2042

US 11236139

Combination immunotherapy

The United States Government represented by the Department of Veterans Affairs · Granted Feb 1, 2022 · Expires Jan 27, 2042

US 11230590

Hyperimmunized egg product for treatment of necrotic enteritis in poultry

United States of America as represented by the Secretary of the Air Force · Granted Jan 25, 2022 · Expires Jan 20, 2042

US 11224626

Methods of identifying bacteriophages that can infect and kill host-adapted infectious pathogenic bacteria

United States of America as represented by the Secretary of the Air Force · Granted Jan 18, 2022 · Expires Jan 13, 2042

US 11213513

Compositions and methods for promoting hair growth with Mpc1 inhibitors

The Regents of the University of California · Granted Jan 4, 2022 · Expires Dec 30, 2041

US 11185600

Contrast agent and its use for imaging

Stichting Radboud universitair medisch centrum · Granted Nov 30, 2021 · Expires Nov 25, 2041

US 11186622

PAC1 receptor agonists (MAXCAPS) and uses thereof

The United States Government represented by the Department of Veterans Affairs · Granted Nov 30, 2021 · Expires Nov 25, 2041

US 11179494

Collagenous tissue repair device

Northwestern University · Granted Nov 23, 2021 · Expires Nov 18, 2041

US 11173150

Method for diagnosing, preventing, and treating neurological diseases

United States Government as represented by the Department of Veterans Affairs · Granted Nov 16, 2021 · Expires Nov 11, 2041

US 11173318

Method of repairing age and disease immune dysfunction and cellular senescence with lymphoid stem cells and then re-applying those for therapeutic use

Advanced Neuroregenerative Therapies, LLC. · Granted Nov 16, 2021 · Expires Nov 11, 2041

US 11160826

Cholesterol lowering drugs for the treatment of hepatic encephalopathy

United States Government as represented by the Department of Veterans Affairs · Granted Nov 2, 2021 · Expires Oct 28, 2041

US 11160779

Methods of providing solriamfetol therapy to subjects with impaired renal function

Jazz Pharmaceuticals Ireland Limited · Granted Nov 2, 2021 · Expires Oct 28, 2041

US 11141398

Methods for decreasing injuries associated with intraoperative hypotension

United States Government as represented by the Department of Veterans Affairs · Granted Oct 12, 2021 · Expires Oct 7, 2041

US 11129808

PKC-delta-I inhibitor formulations and uses thereof

THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERRANS AFFAIRS OFFICE OF THE GENERAL COUNSEL · Granted Sep 28, 2021 · Expires Sep 23, 2041